What is it?
A minimally invasive procedure, called UroLift, for treating lower urinary tract symptoms of a condition called benign prostatic hyperplasia (BPH). BPH is a common condition, affecting 50% of men in their 50s and 80% of men in their 70s. Patients who have this procedure experience a rapid and sustained improvement in symptoms, with significantly less complications and side effects compared to alternative, more invasive treatment options.
Most patients find that they can return home the same day without a catheter, experiencing rapid symptom relief and getting back to their daily lives much more quickly. UroLift can break the cycle of medications and how they make a person feel, without the risks of more invasive surgery.
What are the benefits?
- Productivity savings through shorter length of stay in hospital
- Reduced inpatient resource use (e.g. theatre operating time and associated staffing costs and consumables)
- Improved productivity in outpatient settings due to reduced post-discharge follow-ups, both in primary care settings and in an outpatient setting
- Rapid relief of urinary tract symptoms in men delivering better outcomes for patients
- A 30 minute day-case procedure performed under local anaesthetic or light sedation
- Does not cause tissue injury and therefore avoids the side effects and documented complications associated with current surgical options. UroLift is the only BPH procedure proven to not cause new onset or sustained sexual dysfunction.
- Patients are discharged without a catheter, thereby removing the risk of catheter-associated urinary tract infection.’
Where to start?
- NICE have produced an adoption support resource with insights from the NHS to get started
- Discover more about UroLift at Norfolk and Norwich University Hospitals NHS Trust (NNUH) and key implementation learning points
- Case study from Royal Devon and Exeter NHS Foundation Trust.
- NICE Guidance MTG26
- NHS England Innovation and Technology Payment
- AHSN Innovation and Technology Payment: UroLift
- Email: email@example.com
- AHSN lead: Health Innovation Manchester (HInM) AHSN